Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Response Assessment Maps (TRAMs) in the Delineation of Radiation Necrosis From Tumor Progression After Stereotactic Radiation in Patients With Brain Metastases: A Prospective Study

NCT04033497 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT04033497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04033497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Response Assessment Maps (TRAMs) in the Delineation of Radiation Necrosis From Tumor Progression After Stereotactic Radiation in Patients With Brain Metastases: A Prospective Study
Lead sponsor
Brigham and Women's Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
August 20, 2019
Completion date
July 1, 2028
Enrollment
101 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor